ArticleWorld journal of otorhinolaryngology - head and neck surgery2026
Audiological Characteristics in Vestibular Schwannoma Patients.
Article in World journal of otorhinolaryngology - head and neck surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Audiological Characteristics in Vestibular Schwannoma Patients.World journal of otorhinolaryngology - head and neck surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Vestibular schwannoma (VS) is a benign tumor that originates from the Schwann cells of the vestibular nerve sheath in the internal auditory canal. This retrospective study collected data from patients with VS who underwent surgical treatment to identify their demographic characteristics and audiometric features. Methods: This retrospective study included 330 VS patients who underwent surgical treatment at the ENT Hospital of Fudan University between April 2017 and December 2019. The demographic information, audiograms, and tumor details of these patients were collected. Demographic and audiometric characteristics were summarized. Correlation analysis was performed to compare the basic characteristics of patients with tumor size, pure-tone threshold average (PTA), and tumor grades. Results: Among the patients, 38.8% (128/330) exhibited predominant high-frequency hearing loss on pure-tone audiometry. Approximately 74.5% (246/330) of patients exhibited moderately severe or worse hearing loss. Of the 211 patients who underwent speech testing, 65.4% (138/211) did not have practical hearing function (American Academy of Otolaryngology-Head and Neck Surgery Class C&D) at the time of surgery. Correlation analysis revealed that symptom duration was the most influential variable. No correlation was found between tumor size and PTA or speech discrimination score (SDS). Multivariate ordered regression analysis identified age over 45 years, symptom duration over 12 months, symmetric threshold difference greater than 15 dB, and SDS lower than 75% as high-risk factors for higher Conclusion: Considering the preservation of postoperative hearing, for patients with lower
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.